Severely debilitating or life-threatening hematologic disorders: nonclinical development of pharmaceuticals
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Guidance for industry
- Contributor(s):
- United States. Department of Health and Human Services, issuing body. United States. Food and Drug Administration, issuing body. Center for Drug Evaluation and Research (U.S.), issuing body.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, March 2019
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Drug Evaluation, Preclinical -- standards Hematologic Diseases -- drug therapy Animals Carcinogenicity Tests Cytotoxicity Tests, Immunologic Drug Therapy, Combination Drug-Related Side Effects and Adverse Reactions Immunologic Tests Mutagenicity Tests Pediatrics Pharmacokinetics Photochemistry Safety Toxicity Tests Humans United States United States. Department of Health and Human Services. United States. Food and Drug Administration.
- Genre(s):
- Technical Report
- Copyright:
- The National Library of Medicine believes this item to be in the public domain. (More information)
- Extent:
- 1 online resource (1 PDF file (9 pages)).
- NLM Unique ID:
- 101760012 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101760012